Studies the Medtronic 780G system in children and youth with type 1 diabetes
Observes young people with type 1 diabetes using the Medtronic 780G insulin system.
Key facts
- Who runs it
- Sheba Medical Center
- Where
- Ramat Gan, IsraelSee the site
- Trial code
- Registry title
- Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 1 Jun 2023
- Planned end
- 1 Jul 2026
- Type of study
- Observational
- Treatments tested
- Medtronic 780G® hybrid closed loop
- Record updated
- 9 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people with type 1 diabetes who are starting to use the Medtronic 780G system.
- Age
- From 1 year to 21 years.
- Sex
- All sexes can join.
- Disease stage
- Type 1 diabetes for at least 6 months.
- Earlier treatment
- Must be starting to use the 780G system.
Main reasons for not taking part
- Children under 1 year of age
- Children without a 780G system
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage
Who cannot take part
- Children under the age of 1 year Children without 780G system
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 1 and 21 years old?
Where in Israel
- Sheba medical centerRamat Gan, IsraelContact: Noah GruberTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.
Treatments tested
- Medtronic 780G® hybrid closed loop
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Title: Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes: AWeSoMe Study Group Prospective Trial
- Plain-language title
- Studies the Medtronic 780G system in children and youth with type 1 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05908708, who can take part
- Record updated
- 9 April 2026